Relationship EUS-elastography findings and some fobrotic proteins

Relationship EUS-elastography findings and some fobrotic proteins - EUS-elastograohy and SPARC

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016033

Enrollment

Registered

2014-12-22

Start date

2014-12-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

locally advanced pancreas cancer

Interventions

The relationship EUS-elastographic findings and immunohistochemical findings

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: EUS-elastography is performed as pre-operative imaging finidings. Surgical resection could be performed and immunohistochemical examination could be performed this specimes.

Exclusion criteria

Exclusion criteria: pre-operative chemotheraphy and/or chemoradiotheraphy cases.

Design outcomes

Primary

Measure	Time frame
The relationship the classification of EUS-elastographic findings and immunohistochemical finidings of the pancreas cancer.	—

Countries

Japan

Contacts

Public ContactNoritoshi Kobayashi

Yokohama City University Hospital Medical Oncology

norikoba@yokohama-cu.ac.jp+81457872623

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026